Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011860 (
type 2 diabetes
)
57,723
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
APSL (active peptide from shark liver) is a hepatic stimulator cytokine from the liver of Chiloscyllium. It can effectively protect islet cells and improve complications in mice with alloxan-induced diabetes. Here, we demonstrate that the APSL sequence is present in the N-terminus of novel TBC (Tre-2, Bub2 and Cdc16) domain family, member 15 (
TBC1D15
) from Chiloscyllium plagiosum. This shark
TBC1D15
gene, which contains an ORF of 2088 bp, was identified from a cDNA library of regenerating shark liver. Bioinformatic analysis showed that the gene is highly homologous to
TBC1D15
genes from other species. Moreover, the N-terminus of shark
TBC1D15
contains a motif of unknown function (DUF3548), which encompasses the APSL fragment. Rab-GAP activity analysis showed that shark
TBC1D15
is a new member of the
TBC1D15
family. These results demonstrated that shark
TBC1D15
possesses Rab-GAP activity using Rab7 as a substrate, which is a common property of the
TBC1D15
family. The involvement of APSL at the N-terminus of
TBC1D15
also demonstrates that this protein might be involved in insulin signaling and may be associated with the development of
type 2 diabetes
. The current findings pave the way for further functional and clinical studies of these proteins from marine sources.
...
PMID:A New Member of the TBC1D15 Family from Chiloscyllium plagiosum: Rab GTPase-Activating Protein Based on Rab7 as a Substrate. 2598 91